Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662521-25-000005
Filing Date
2025-10-01
Accepted
2025-10-01 18:29:35
Documents
1
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 form4-10012025_101031.html 4  
1 form4-10012025_101031.xml 4 5714
  Complete submission text file 0001662521-25-000005.txt   7363
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
Connaughton Bernadette (Reporting) CIK: 0001662521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 251365956